本报道最初发表于Endpoints News。请点击这里查看原文
As far as deals go, this year’s JPM conference was relatively quiet. We didn’t see any major announcements over the past three days. But there’s plenty of cash floating around the industry, and executives at many big pharma companies said they’re scouting for assets. Many of the people we talked to this week are expecting a good year for biopharma.
就交易而言，今年的JPM大会相对平静。过去三天我们没有看到任何重磅公告。但行业里资金充裕，许多大型制药公司的高管表示他们正在物色资产。本周我们交流的许多人都预期生物医药会有个好年景。
您已阅读3%（473字），剩余97%（13259字）包含更多重要信息，订阅以继续探索完整内容，并享受更多专属服务。